Crowdonomics
NAVIX HEALTH

Reg CF · Common Stock · Jun 2024

ClosedReached targetReg CFCommon Equity
via StartEngine · last checked Oct 4, 2026View campaign
Raised
$125K / $1.2M max
10% of ceiling · target hit day 3
Investors
181
$779.7 avg
Post-money valuation
$7.7M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$140K$70K$0
179900
Jun 26, 2024 · openedSep 26, 2024 · last reading
Target ($15K) hit — Jun 29, 2024, day 3Deadline Sep 25, 2024

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via StartEngine, last checked Oct 4, 2026; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2022–FY2023 · hover for source
$5K
−$211K
FY2022
$28K
−$367K
FY2023
RevenueNet income
Metric
FY2022 reviewed
FY2023 reviewed
Income statement
Revenue
$4,900
$28,210
Cost of goods sold
$0
$0
Gross margin
100%
100%
Net income
-$211,057
-$366,678
Taxes paid
$0
$0
Balance sheet
Cash
$110,678
$179,870
Accounts receivable
$0
$0
Total assets
$414,964
$828,616
Short-term debt
$175,478
$355,577
Long-term debt
$0
$0
Total liabilities
$175,478
$355,577
Other
Headcount
—
25

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$7.5M
Post-money$7.7M
Price / share$0.48
Shares offered31,250

Perks

Invest $2,000+ within the first 2 weeks and receive 3% bonus shares · until Jul 9, 20243% bonus$2K+

Offering details

Target$15,000
Max$1,235,000
Min investment$200
OpenedJun 26, 2024
DeadlineSep 25, 2024
ClosedSep 25, 2024
Days active91

Links & provenance

Source: Manual
0001665160-24-001030
Last synced Aug 18, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.